Responsiveness of the Scale for the Assessment and Rating of Ataxia and Natural History in 884 Recessive and Early Onset Ataxia Patients
Annals of Neurology · 2023-09 · 94 (3) · 470-485
DOI: 10.1002/ana.26712 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Neurology, online erschienen am 12.06.2023. Verfasst von Andreas Traschütz und 24 weiteren Autor:innen. Beteiligte Einrichtung: Research Division "Translational Genomics of Neurodegenerative Diseases," Hertie Institute for Clinical Brain Research and Center of Neurology, Unive…. Hauptthemen laut MEDLINE: Spinocerebellar Ataxias, Cerebellar Ataxia. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Bundesministerium für Bildung und Forschung, Deutsche Forschungsgemeinschaft, Eberhard Karls Universität Tübingen.
Abstract (Originalsprache)
Objective
The Scale for the Assessment and Rating of Ataxia (SARA) is the most widely applied clinical outcome assessment (COA) for genetic ataxias, but presents metrological and regulatory challenges. To facilitate trial planning, we characterize its responsiveness (including subitem‐level relations to ataxia severity and patient‐focused outcomes) across a large number of ataxias, and provide first natural history data for several of them.
Methods
Subitem‐level correlation and distribution‐based analysis of 1,637 SARA assessments in 884 patients with autosomal recessive/early onset ataxia (370 with 2–8 longitudinal assessments) were complemented by linear mixed effects modeling to estimate progression and sample sizes.
Results
Although SARA subitem responsiveness varied between ataxia severities, gait/stance showed a robust granular linear scaling across the broadest range (SARA < 25). Responsiveness was diminished by incomplete subscale use at intermediate or upper levels, nontransitions (“static periods”), and fluctuating decreases/increases. All subitems except nose‐finger showed moderate‐to‐strong correlations to activities of daily living, indicating that metric properties—not content validity—limit SARA responsiveness. SARA captured mild‐to‐moderate progression in many genotypes (eg, SYNE1 ‐ataxia: 0.55 points/yr, ataxia with oculomotor apraxia type 2: 1.14 points/yr, POLG ‐ataxia: 1.56 points/yr), but no change in others (autosomal recessive spastic ataxia of Charlevoix‐Saguenay, COQ8A ‐ataxia). Whereas sensitivity to change was optimal in mild ataxia (SARA < 10), it substantially deteriorated in advanced ataxia (SARA > 25; 2.7‐fold sample size). Use of a novel rank‐optimized SARA without subitems finger‐chase and nose‐finger reduces sample sizes by 20 to 25%.
Interpretation
This study comprehensively characterizes COA properties and annualized changes of the SARA across and within a large number of ataxias. It suggests specific approaches for optimizing its responsiveness that might facilitate regulatory qualification and trial design. ANN NEUROL 2023;94:470–485
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Research Division "Translational Genomics of Neurodegenerative Diseases," Hertie Institute for Clinical Brain Research and Center of Neurology, University of Tübingen, Tübingen, Germany.
- German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
- Movement Disorders Unit, Department of Neurology and Clinical Neurophysiology, Institute of Biomedicine of Seville, Virgen del Rocío University Hospital/CSIC/University of Seville, Seville, Spain.
- Center for Biomedical Research Network on Neurodegenerative Diseases, Madrid, Spain.
- Department of Neurology, Hautepierre Hospital, University Hospitals of Strasbourg, Strasbourg, France.
- Federation of Translational Medicine of Strasbourg, University of Strasbourg, Strasbourg, France.
ORCID-Profile: Andreas Traschütz, Cynthia Gagnon, Alexander Münchau, Filippo M Santorelli, Matthis Synofzik
Förderung
- Bundesministerium für Bildung und Forschung
- Deutsche Forschungsgemeinschaft
- Eberhard Karls Universität Tübingen
- Fonds Wetenschappelijk Onderzoek
- Horizon 2020 Framework Programme
- Ministero della Salute
- Szegedi Tudományegyetem
Zitieren
APA
Traschütz, A., Adarmes-Gómez, A. D., Anheim, M., Baets, J., Brais, B., Gagnon, C., Gburek-Augustat, J., Doss, S., Hanağası, H. A., Kamm, C., Klivenyi, P., Klockgether, T., Klopstock, T., Minnerop, M., Münchau, A., Renaud, M., Santorelli, F. M., Schöls, L., Thieme, A., …, & Synofzik, M. (2023). Responsiveness of the Scale for the Assessment and Rating of Ataxia and Natural History in 884 Recessive and Early Onset Ataxia Patients. Annals of Neurology, 94(3), 470-485. https://doi.org/10.1002/ana.26712
Vancouver
Traschütz A, Adarmes-Gómez AD, Anheim M, Baets J, Brais B, Gagnon C, et al. Responsiveness of the Scale for the Assessment and Rating of Ataxia and Natural History in 884 Recessive and Early Onset Ataxia Patients. Annals of Neurology. 2023;94(3):470-485. doi:10.1002/ana.26712
BibTeX
@article{Traschtz2023,
author = {Traschütz, Andreas and Adarmes-Gómez, Astrid D and Anheim, Mathieu and Baets, Jonathan and Brais, Bernard and Gagnon, Cynthia and Gburek-Augustat, Janina and Doss, Sarah and Hanağası, Haşmet A and Kamm, Christoph and Klivenyi, Peter and Klockgether, Thomas and Klopstock, Thomas and Minnerop, Martina and Münchau, Alexander and Renaud, Mathilde and Santorelli, Filippo M and Schöls, Ludger and Thieme, Andreas and Vielhaber, Stefan and van de Warrenburg, Bart P and Zanni, Ginevra and Hilgers, Ralf-Dieter and PREPARE Consortium, PREPARE Consortium and Synofzik, Matthis},
title = {Responsiveness of the Scale for the Assessment and Rating of Ataxia and Natural History in 884 Recessive and Early Onset Ataxia Patients},
journal = {Annals of Neurology},
year = {2023},
volume = {94},
number = {3},
pages = {470--485},
doi = {10.1002/ana.26712}
}
EUVIMED